Teva entered the FDA’s shame list
The Food and Drug Administration (FDA) published the list of shame, which includes 40 pharmaceutical manufacturers trying to block generic drug competition. Among the companies are giants such as Novartis, More...
Allergen, The Mohawk Indian Tribe and What is The Connection to Teva
The creative attempt by the drug company Allergan to fight generic competition by Mylan and Teva failed, and not for the first time. The appeals committee of the US Patent Office on Friday rejected an More...
The UK court overturned Teva’s Copaxone patent
The British Supreme Court ruled Thursday in favor of Mylan and its Dutch partner Synthon, and canceled all Teva’s Copaxone for 40 mg in the country based on obviousness. A statement by Mylan More...
Perrigo inaugurates $46 million factory in Israel
Perrigo pharmaceutical firm opened a new factory in south of Israel, Reuters reports on Wednesday. The company invested some $45 million to expand its facility. The generic drugmaker will manufactures More...
Perrigo Taking Actions To Fend off Mylan, Deliver Shareholder Value Far Superior To Mylan Offer
Perrigo, which is the target of a hostile takeover bid by Mylan, said Thursday that it would reduce its workforce by approximately 800 employees, or approximately 6 percent of its current global More...
Mylan to pitch today to Perrigo shareholders in hostile takeover bid
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout to Perrigo shareholders. Perrigo has rejected the $27 billion buyout More...
Mylan Begins $27 billion Hostile Bid for Perrigo
Mylan N.V. on Monday announced that it has officially took its $27 billion takeover bid directly to shareholders of Perrigo Company plc (NYSE: PRGO; TASE). In April 29th Mylan made the same offer, More...
Perrigo CEO: Mylan’s propose shows sign of desperation
Perrigo Company plc (NYSE: PRGO; TASE) today responded to the announcement that Mylan N.V. has lowered the acceptance condition for its proposed unsolicited offer to acquire Perrigo from not less than More...
Mylan might make do with only 50% of Perrigo
Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that More...
Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...